These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15145510)

  • 1. Treatment of small cell lung cancer in the elderly based on a critical literature review of clinical trials.
    Sekine I; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Saijo N
    Cancer Treat Rev; 2004 Jun; 30(4):359-68. PubMed ID: 15145510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer in the elderly.
    Gridelli C; Langer C; Maione P; Rossi A; Schild SE
    J Clin Oncol; 2007 May; 25(14):1898-907. PubMed ID: 17488989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly.
    Schild SE; Stella PJ; Brooks BJ; Mandrekar S; Bonner JA; McGinnis WL; Mailliard JA; Krook JE; Deming RL; Adjei AA; Jatoi A; Jett JR
    Cancer; 2005 Jun; 103(11):2349-54. PubMed ID: 15852407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
    Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer.
    Fukuda M; Soda H; Soejima Y; Fukuda M; Kinoshita A; Takatani H; Kasai T; Nagashima S; Kawabata S; Doi S; Kohno S; Oka M
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):601-6. PubMed ID: 16463061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
    J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.
    Hallqvist A; Rylander H; Björk-Eriksson T; Nyman J
    Acta Oncol; 2007; 46(7):969-74. PubMed ID: 17851846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis--a Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) study.
    Ardizzoni A; Favaretto A; Boni L; Baldini E; Castiglioni F; Antonelli P; Pari F; Tibaldi C; Altieri AM; Barbera S; Cacciani G; Raimondi M; Tixi L; Stefani M; Monfardini S; Antilli A; Rosso R; Paccagnella A
    J Clin Oncol; 2005 Jan; 23(3):569-75. PubMed ID: 15659503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and treatment in elderly patients with small cell lung cancer: a retrospective study.
    Li J; Chen P; Dai CH; Li XQ; Bao QL
    Geriatr Gerontol Int; 2009 Jun; 9(2):172-82. PubMed ID: 19740361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoradiotherapy for limited-disease small-cell lung cancer in elderly patients aged 75 years or older.
    Shukuya T; Takahashi T; Harada H; Ono A; Akamatsu H; Taira T; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi K; Yamamoto N
    Jpn J Clin Oncol; 2013 Feb; 43(2):176-83. PubMed ID: 23225910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older.
    Shimizu T; Sekine I; Sumi M; Ito Y; Yamada K; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    Jpn J Clin Oncol; 2007 Mar; 37(3):181-5. PubMed ID: 17426103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer.
    De Ruysscher D; Pijls-Johannesma M; Bentzen SM; Minken A; Wanders R; Lutgens L; Hochstenbag M; Boersma L; Wouters B; Lammering G; Vansteenkiste J; Lambin P
    J Clin Oncol; 2006 Mar; 24(7):1057-63. PubMed ID: 16505424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of small-cell lung cancer in elderly patients.
    Pallis AG; Shepherd FA; Lacombe D; Gridelli C
    Cancer; 2010 Mar; 116(5):1192-200. PubMed ID: 20082450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small cell lung cancer: strategies to optimize chemotherapy response.
    Psyrri A; Murren J
    Cancer J; 2001; 7 Suppl 1():S28-34. PubMed ID: 11504283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
    Früh M; Rolland E; Pignon JP; Seymour L; Ding K; Tribodet H; Winton T; Le Chevalier T; Scagliotti GV; Douillard JY; Spiro S; Shepherd FA
    J Clin Oncol; 2008 Jul; 26(21):3573-81. PubMed ID: 18640938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
    J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
    Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.